If you have been reading about LC-MS and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-10-25. Numbers and descriptions here follow the published literature rather than marketing material.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow solid | Visual description varies with purity and source |
| Solubility | Soluble in DMSO and ethanol; poorly soluble in water | Organic stock solutions are common in research |
| Typical storage | -20 °C, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Typical analytical method | LC-MS or HPLC-UV | Reference standards are needed for quantification |
| Molar mass | Approximately 437.9 g/mol | Calculated from the reported free-base formula |
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
=== Pancreatitis and pancreatic cancer === An association of the DPP-IV inhibitor class with pancreatic problems has been proposed, mainly based on case reports associated with the DPP-IV inhibitor sitagliptin and several incretin mimetics including exenatide. A 2013 study of the DPP-4 inhibitor sitagliptin reported found "worrisome changes in the pancreases of the rats that could lead to pancreatic cancer". A second paper by the same authors reported an increase in precancerous lesions in the pancreases of organ donors who had taken GLP-1 inhibitors. In response to these reports, the United States FDA and the European Medicines Agency each undertook independent reviews of all clinical and preclinical data related to the possible association of DPP-IV inhibitors with pancreatic cancer. In a joint letter to the New England Journal of Medicines, the agencies stated that "Both agencies agree that assertions concerning a causal association between incretin-based drugs and pancreatitis or pancreatic cancer, as expressed recently in the scientific literature and in the media, are inconsistent with the current data. The FDA and the EMA have not reached a final conclusion at this time regarding such a causal relationship.
== Georgian Parliamentary Commission Report == A Georgian parliamentary commission published a report on the war on 18 December 2008. The report said in its beginning that "Russia's aggression against Georgia has not started in August, 2008". The report, after recounting the events in Abkhazia and South Ossetia in the 1990s, proceeded to describe pre-war timeline in detail. It also said that inability of the Georgian authorities "to de-legitimize the presence of Russian peacekeepers can be considered the major shortcoming of the Georgian authorities in a pre-August period." The Russian peacekeepers were full-fledged combatants in the war, according to the commission and they had attacked the Georgian citizens before the war. The report said that officials did not succeed "to properly analyze" the scale of the threat from Russia before August 2008. The National Security Council was also criticized because it had "failed to plan the actions in a timely manner." The commission said that there was a lack of coordination between officials during the war and the specially designated formal procedures were not observed.
== Regulatory status == PRP is not regulated by the FDA because, like certain other human tissue and blood products, it is exempted from the traditional regulatory pathways; any use of PRP in a clinical setting is therefore considered "off label". The medical devices used to prepare PRP, however, are subject to FDA clearance.
== Methods of study == As defined above, haptotaxis is the motility of cells up a gradient of substrate bound molecules. There is a wide variety of procedures to set up this gradient in vitro for the study of haptotaxis. The two main categories can be classified into either continuous or digital. Both types are relatively easy to produce, but digital gradients give more accurate concentration calculations. Overall, the methods in use currently can be improved to mirror the in vivo environment more, as the resolution of the gradients is not as sharp in vitro as they are in vivo. Also, biological gradients have the ability to change geometry, which current models in vitro cannot mimic. These gradients are useful in gaining understanding of the basics of haptotaxis, but because of the complex and fluid nature of these gradients, a deeper understanding of the in vivo condition is difficult to ascertain.
Prime Minister Rishi Sunak meets with US president Joe Biden at the Grand Central Hotel in Belfast. Biden makes a keynote speech at the Ulster University during which he urges Northern Ireland's politicians to restore the power-sharing government. A 74-year-old man is extradited from Pakistan and charged with murdering police officer Sharon Beshenivsky in November 2005. Tesco reduces the price of a four pint bottle of milk from £1.65 to £1.55 following a cut in wholesale prices. Coronation of Charles III and Camilla: Buckingham Palace confirms that the Duke of Sussex will attend the coronation, but that the Duchess will remain in the United States with their children. 13 April Data published by the Office for National Statistics shows a 0% growth in the UK economy during February as growth in the construction industry was offset by industrial action. Publication of the Deciphering Developmental Disorders study, a study involving children with development disorders, which has identified 60 new health conditions. Sainsbury's follows Tesco in cutting the price of milk. A report published by Diabetes UK indicates the UK is heading for what the charity describes as a "rapidly escalating diabetes crisis", with 4.3 million people experiencing a form of diabetes, a further 850,000 estimated to be living with the disease but unaware of it, and another 2.4 million people at risk of developing the condition. Cases of diabetes are more prevalent in less affluent areas of the country. 14 April Ford receives government approval for its "BlueCruise" Level 2 autonomous driving technology.
Sources: en.wikipedia.org
All triterpenoids are synthesized via the cyclization of the C30 isoprenoid chain, squalene. Eukaryotes use oxidosqualene cyclase and several other enzymes to create the tetracyclic skeleton found in steroids, a process that requires molecular oxygen. Bacteria use a similar enzyme (shc) to create the pentacyclic hopanoid precursor, diploptene; however, this biosynthesis does not require oxygen. It was recently discovered that tetrahymanol-producing bacteria form diploptene using shc then elongate the final cyclopentane into a fifth ring using tetrahymanol synthase (ths). It is unknown whether bacteria modify diploptene into other hopene molecules before creating tetrahymanol. It has also been found with a methylation at the C-3 site. Eukaryotes that live in anaerobic environments cannot synthesize their own sterols because of a lack of molecular oxygen. These organisms can gain sterols through predation. However, there can be times of sterol starvation. Tetrahymanol biosynthesis does not require oxygen, and can substitute readily for sterols. It is hypothesized that ciliates synthesize tetrahymanol in response to lack of oxygen and exogenous sterols. The gene for tetrahymanol synthase was found in the genomes of many genera of alpha-, delta-, and gammaproteobacteria, including Rhodopseudomonas, Bradyrhizobium and Methylomicrobium.
At the October 1907 meeting of the American Roentgen Ray Society, Rome Vernon Wagner, an X-ray tube manufacturer, reported that he had begun carrying a photographic plate in his pocket and developing it every evening. This allowed him to determine how much radiation he had been exposed to. This was the forerunner of the film dosimeter. His efforts came too late, as he had already developed cancer and died six months after the conference. In the 1920s, the physical chemist John Eggert (1891-1973) played a key role in the introduction of film dosimetry for routine personal monitoring. Since then, it has been successively improved and, in particular, the evaluation technique has been automated since the 1960s. At the same time, Hermann Joseph Muller (1890-1967) discovered mutations as genetic consequences of X-rays, for which he was awarded the Nobel Prize in 1946. At the same time, the roentgen (R) was introduced as a unit for quantitative measurement of radiation exposure. A dosimeter for film is divided into multiple segments, each containing a light- or radiation-sensitive film surrounded by layers of copper and lead with varying thickness. The degree of radiation penetration determines whether the segment is not blackened or blackened to varying degrees. The absorbed radiation effect during the measurement time is summed up, and the radiation dose can be determined from the blackening. Guidelines for evaluation exist, with those for Germany being published in 1994 and last updated on December 8, 2003.
=== Addison's Disease === Corticotropic cells can also be the cause of Addison's disease in some instances. Addison's disease is characterized adrenal insufficiency, which is defined as the underproduction of glucocorticoids by the adrenal cortex. If the corticotropes underproduce ACTH this can result in secondary adrenal insufficiency, causing the adrenal glands to underproduce cortisol. This can be caused by tumors of the anterior pituitary or hypothalamus, inflammation, or surgery. This ultimately results in the underproduction of cortisol, which has many detrimental symptoms. Symptoms of Addison's disease include:
Modified castor oil - much like cellulose, castor oil has hydroxyl groups, unlike other oils which at most have double bonds, which castor oil also has, but most substitutions occur at the hydroxyl moieties, allowing exotic derivatives with myriad properties. The most recent advances in rheology modifiers have been in this category. The BASF corporation has a new line based on castor oil derivatives, for example. Organosilicones - Silicone resins, dimethicones, and modified silicones simplify formulation somewhat, a borrowing from cosmetics. All of the above rheology modifiers are used in the 0.2% to 2.0% range
=== Ocular hypertension === Ocular hypertension (increased pressure within the eye) is an important risk factor for glaucoma, but only about 10–70% of people, depending on ethnic group, with primary open-angle glaucoma actually have elevated ocular pressure. Ocular hypertension—an intraocular pressure above the traditional threshold of 21 mmHg (28 hPa) or even above 24 mmHg (32 hPa)—is not necessarily a pathological condition, but it increases the risk of developing glaucoma. A study with 1636 persons aged 40–80 who had an intraocular pressure above 24 mmHg in at least one eye, but no indications of eye damages, showed that after five years, 9.5% of the untreated participants and 4.4% of the treated participants had developed glaucomatous symptoms, meaning that only about one in 10 untreated people with elevated intraocular pressure will develop glaucomatous symptoms over that period. Given these results, the clinical decision to treat everyone with elevated intraocular pressure with glaucoma therapy as a preventative measure is a matter of debate. As of 2018, most ophthalmologists favored treatment of those with additional risk factors. For eye pressures, a value of 28 hPa (21 mmHg) above atmospheric pressure 1,010 hPa (760 mmHg) is often used, with higher pressures leading to a greater risk. However, some may have high eye pressure for years and never develop damage. Conversely, optic nerve damage may occur with normal pressure, known as normal-tension glaucoma.
Sources: en.wikipedia.org
== Signs and symptoms == NL/NLD most frequently appears on the patient's shins, often on both legs, although it may also occur on forearms, hands, trunk, and, rarely, nipple, penis, and surgical sites. The lesions are often asymptomatic, but may become tender and ulcerate when injured. The first symptom of NL is often a "bruised" appearance (erythema) that is not necessarily associated with a known injury. The extent to which NL is inherited is unknown. NLD appears as a hardened, raised area of the skin. The center of the affected area usually has a yellowish tint, while the area surrounding it is a dark pink. The affected area can spread or turn into an open sore. When this happens, the patient is at greater risk of developing ulcers. If an injury to the skin occurs on the affected area, it may not heal properly, or it will leave a dark scar.
Naturally occurring cadmium (48Cd) is composed of 8 isotopes. For two of them, natural radioactivity has been observed, and three others are predicted to possibly decay though this has not been observed; it may be presumed the half-lives are extremely long. The two natural radioactive isotopes are 113Cd (beta decay, half-life 8.04×1015 years) and 116Cd (double beta decay, half-life 2.69×1019 years). The other three are 106Cd, 108Cd (double electron capture), and 114Cd (double beta decay); only lower limits on their decays have been set. Only three isotopes—110Cd, 111Cd, and 112Cd—are theoretically stable. Among the isotopes absent in natural cadmium, the most long-lived are 109Cd with a half-life of 461.3 days, and 115Cd with a half-life of 53.46 hours. All of the remaining radioactive isotopes have half-lives that are less than 7 hours and the majority of these are less than 5 minutes. This element also has 12 known meta states, with the most stable being 113mCd (t1/2 13.9 years), 115mCd (t1/2 44.6 days) and 117mCd (t1/2 3.44 hours). The known isotopes of cadmium range from 95Cd to 132Cd. The primary decay mode before the stable isotope 112Cd is electron capture to isotopes of silver, and after, beta emission to isotopes of indium. A 2021 study has shown at high ionic strengths, cadmium isotope fractionation mainly depends on its complexation with carboxylic sites. At low ionic strengths, nonspecific cadmium binding induced by electrostatic attractions plays a dominant role and promotes cadmium isotope fractionation during complexation.
=== Military lull (August) === Active hostilities slowed in August 2026, when the formal 60-day deadline set by the June MoU officially expired. The Strait of Hormuz remained disrupted during this period and mediators Oman and Qatar were involved in backdoor diplomacy, slowing world energy shipping to a fraction of its pre-war volume.
Martín-Francés et al. (2026) interpret the molar wear in the Sima de los Huesos hominins as suggestive of a mixed diet including similar proportions of meat and plant foods. Parfitt & Bello (2026) describe a 480,000-years-old knapping tool made on an elephant bone from the Boxgrove Palaeolithic site (United Kingdom), representing the oldest case of an elephant bone being used as a raw material in Europe reported to date. Nicoud et al. (2026) study the chronology of bifacial occurrences from Valle Giumentina (Italy), reporting evidence of shifts in the biface structure within two levels from Marine Isotope Stage 12, and interpret evidence from the studied site as consistent with repeated reinventions of the biface in Europe during the Lower Paleolithic. A study on the Acheulean handaxe variability in southeastern Britain, interpreted as consistent with presence of distinct regional cultural groups during the Marine Isotope Stage 11, is published by White et al. (2026). García-Martínez et al. (2026) provide the first proteomics-based sex identification of a hominin tooth from the Middle Pleistocene of western Europe, using the analysis of the presence of amelogenin to attribute a hominin molar from the Middle Pleistocene site of Ruidera (Spain) to a male individual. Rosas et al.
Sources: en.wikipedia.org
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.
The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.
Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.